Stock Taper Q4 2024 Performance:
Consolidated net sales reached $620.3 million, a 13.8% increase year-over-year.
Adjusted EBITDA for Q4 was $118 million, up 29% from the previous year.
Consolidated net income stood at $11.9 million, down from Q4 2023 due to a large gain from the sale of the Marucci business in the prior year.
Adjusted earnings for the quarter were $46.6 million, reflecting a 34% increase year-over-year.
Cash flow from operations was $9 million, with significant capital expenditures of $22.9 million.
Full Year 2024 Performance:
Achieved double-digit sales growth and increased adjusted EBITDA by over 30%.
Pro forma adjusted EBITDA for the consumer vertical grew over 30%, despite a $12 million write-down related to PFAS regulations impacting the 5.11 subsidiary.
Acquisitions:
Acquired Honey Pot, focusing on the feminine hygiene market, and Lifoam, enhancing capabilities in temperature-controlled packaging.
Divestitures:
Sold Ergobaby for $104 million and divested the Crosman airgun business to streamline operations.
Capital Structure:
Raised over $115 million in preferred equity to improve balance sheet leverage and reduced overall cost of capital.
Share Buybacks:
Repurchased over 400,000 shares of CODI common stock in Q4, driven by perceived undervaluation.
2025 Expectations:
Projected consolidated subsidiary adjusted EBITDA between $570 million and $610 million.
Branded consumer vertical expected to deliver adjusted EBITDA between $440 million and $465 million.
Industrial vertical projected adjusted EBITDA between $130 million and $145 million.
Anticipated adjusted earnings for the year between $170 million and $190 million.
Capital expenditures expected to be between $80 million and $90 million, primarily for growth investments.
Economic and Geopolitical Risks:
Noted potential headwinds from geopolitical uncertainties, including tariffs and trade tensions that could impact operations.
5.11 Performance:
Faced challenges due to PFAS regulations, leading to a significant write-down and affecting overall performance.
Market Conditions:
Despite a slight recovery in M&A activity, the overall market remains subdued, with concerns about the impact of tariffs on supply chains.
Lugano's Growth:
Expected to continue strong growth, with management optimistic about maintaining momentum despite potential margin dilution from new salon openings.
5.11 Strategy:
Plans for a brand refresh and new product introductions in 2025 to improve performance after a challenging year.
Tariff Preparedness:
Management has diversified supply chains over the past few years to mitigate tariff impacts, positioning subsidiaries well against competitors.
M&A Activity Outlook:
Management anticipates a slight increase in M&A activity in 2025, driven by a recovering market and a strong balance sheet. Overall, CODI reported strong financial results for Q4 2024 and the full year, with strategic acquisitions and a focus on long-term value creation. However, challenges remain, particularly regarding regulatory impacts and geopolitical risks. The outlook for 2025 is cautiously optimistic, with expectations for continued growth across its subsidiaries.
SOURCE: Q4 2024 EARNINGS CALL TRANSCRIPT